| Literature DB >> 35009084 |
Sara Rodrigo1, Carlos García-Latorre1, Oscar Santamaria2.
Abstract
Many fungi, especially endophytes, have been found to produce multiple benefits in their plant hosts, with many of these benefits associated with the protection of plants against fungal diseases. This fact could be used in the development of new bio-products that could gradually reduce the need for chemical fungicides, which have been associated with multiple health and environmental problems. However, the utilization of the living organism may present several issues, such as an inconsistency in the results obtained and more complicated management and application, as fungal species are highly influenced by environmental conditions, the type of relationship with the plant host and interaction with other microorganisms. These issues could be addressed by using the bioactive compounds produced by the fungus, in cases where they were responsible for positive effects, instead of the living organism. Multiple bioactive compounds produced by fungal species, especially endophytes, with antifungal properties have been previously reported in the literature. However, despite the large amount of these metabolites and their potential, extensive in-field application on a large scale has not yet been implemented. In the present review, the main aspects explaining this limited implementation are analyzed, and the present and future perspectives for its development are discussed.Entities:
Keywords: biopesticides; fungal endophytes; large-scale application; metabolites; plant diseases
Year: 2021 PMID: 35009084 PMCID: PMC8747711 DOI: 10.3390/plants11010081
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Graphical abstract of the different categories in which the fungal metabolites with antifungal properties are included, indicating the percentage of compounds in each category.
Metabolites produced by fungi, especially fungal endophytes, which have shown a certain control of phytopathogens.
| Metabolite(s) | Producer Fungi | Fungal Pathogen(s) | Action 1 | Conditions 2 | Efficacy 3 | Ref. |
|---|---|---|---|---|---|---|
| (12R)-12-Hydroxymonocerin | A | IV | 3% | [ | ||
| 3-(5-Oxo-2,5-dihydrofuran-3-yl) propanoic acid | A | IV | 2-fold | [ | ||
| 4-Methylmellein, | A | IV | 35% | [ | ||
| 4-Prenyloxyclavatol | A | IV | 63% | [ | ||
| 5-Methylmellein | A | IV | 5% | [ | ||
| 5-(Undeca-3′,5′,7′-trien-1′-yl) | A | IV | 49% | [ | ||
| 5-(Undeca-3′,5′,7′-trien-1′-yl) | 12% | |||||
| Bicolorin D | A | IV | 13% | [ | ||
| IP-A | 57% | |||||
| Brefeldin A | A | IV | 8-fold | [ | ||
| Cercosporamide | A | IV | - | [ | ||
| Cuminic acid | A | IV | - | [ | ||
| Epirodin | A | IV, IP-A | - | [ | ||
| Ergot alkaloids | - | A | - | - | [ | |
| Exserolide C | A | IV | 3% | [ | ||
| Ferric chloride, | - | A | IV | - | [ | |
| Geoxantethers A and B | Fungus from | A | IV | 16% | [ | |
| Griseofulvin | A | IV | - | [ | ||
| Guignardianone C | A | IV | 52% | [ | ||
| Hexadecanoic acid, 2,3-bis ((trimethylsilyl) oxy) propyl ester | A | IV | 25% | [ | ||
| Leucinostatins A and B | A | IV | - | [ | ||
| Macrosporin | A | IV | 10% | [ | ||
| Methyl dichloroasterrate | A, ISR | IV | 17% | [ | ||
| Monocerin | A | IV, IP-A | - | [ | ||
| Nigrosporamide A | A | IV | 10.83-fold | [ | ||
| Not identified | A | IV | - | [ | ||
| Not identified | A | IP-F | - | [ | ||
| Palmitic acid, stearic acid, octadecenoic acid | - | A, ISR, PGP | IV | - | [ | |
| Penicillither | A | IV | 5% | [ | ||
| Penochalasin K | A | IV | 10-fold | [ | ||
| 2.66-fold | ||||||
| Pestalachlorides A, B and C | A | IV | - | [ | ||
| Pretrichodermamide A | A | IV | 2-fold | [ | ||
| Pseudoanguillosporin A | A | IV | 40% | [ | ||
| Pyrenophorol | A | IP-G | - | [ | ||
| Rosellichalasin | A | IV | 32% | [ | ||
| Speciosin U | A | IV | - | [ | ||
| Sporothriolide | A | IV | 60% | [ | ||
| IP-G | 79% | |||||
| Trichodermin | A | IV | 1.44-fold | [ | ||
| 1.21-fold | ||||||
| Versicolorin B | A | IV | - | [ | ||
| Viriditoxin | A | IV; IP-G | - | [ |
1 Mechanism of action involved in the biocontrol: antibiosis (A); induced systemic resistance (ISR); plant growth promotion (PGP). 2 Conditions in which the antifungal bioactivity was obtained: in vitro (IV); in planta (or detached tissues) axenic conditions in laboratory (IP-A); in planta controlled conditions in greenhouse (IP-G); in planta uncontrolled conditions in the field (IP-F). 3 Efficacy: average percentage of efficacy of the biological compound in relation to the positive control (chemical fungicide) used in the corresponding study.
Fungal species authorized by the European Union to be applied against fungal pathogens.
| Fungal Isolate | Applied Crop | Target Fungal Pathogen | Application Form |
|---|---|---|---|
|
| Grapes, tomato, pepper, aubergine | Powdery mildew | Spores |
|
| Pome fruit |
| CFU |
|
| Apples/pears | Postharvest diseases | CFU |
|
| Fruiting and leaf vegetables, seedlings, ornamentals, pot plants, cut flowers, wheat, corn, onion, potato, leek, berries | Seed borne and soil borne fungi, such as | CFU |
|
| Winter rape, lettuce, cucumber, beans, sunflower | Spores | |
|
| Oilseed rape | Oospores | |
|
| Pome fruits | CFU | |
|
| Tomato, pepper, cucumber, courgette, carnation plants growing in the greenhouse | Soil pathogens: | CFU |
|
| Grapevine, tomato | Wood decay diseases. | CFU |
|
| Tomato, pepper, cucumber, courgette | CFU | |
|
| Elm trees | Vascular fungus: | Spores |
(https://ec.europa.eu/food/plant/pesticides/eu-pesticides-database, accessed on 11 November 2021).